Eotaxin protein and gene expression in guinea-pig lungs: Constitutive expression and upregulation after allergen challenge

European Respiratory Journal

Volumn 10, Issue 9, 1997, Pages 1946-1954

  Li, D ^a   Wang, D ^a   Griffiths Johnson, D A ^a   Wells, T N C ^b   Williams, T J ^a   Jose, P J ^a   Jeffery, P K ^a,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Airway; Allergy; Asthma; Eosinophils; Eotaxin

Indexed keywords

ALLERGEN; PROTEIN;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; EOSINOPHIL; EPITHELIUM CELL; GENE EXPRESSION; GUINEA PIG; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROVOCATION TEST; RESPIRATORY EPITHELIUM;

ALLERGENS; ANIMALS; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CYTOKINES; GENE EXPRESSION; GUINEA PIGS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG; MALE; OVALBUMIN; RESPIRATORY HYPERSENSITIVITY; RNA, MESSENGER; UP-REGULATION;

EID: 0030930736     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10091946     Document Type: Article

References (43)

1. Azzawi M, Bradley B, Jeffery PK, et al. Identification of activated T-lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142: 1407-1413.
2. Bradley BL, Azzawi M, Jacobson M, et al. Eosinophils, T-lymphocytes, mast cells, neutrophils and macrophages in bronchial biopsies from atopic asthmatics: comparison with atopic non-asthma and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991; 88: 661-674.
3. Djukanovic R, Wilson JW, Britten KM, et al. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990; 142: 863-871.
4. Azzawi M, Johnston PW, Majumdar S, Kay AB, Jeffery PK. T-lymphocytes and activated eosinophils in asthma and cystic fibrosis. Am Rev Respir Dis 1992; 145: 1477-1482.
5. Corrigan CJ, Kay AB. T-cells and eosinophils in the pathogenesis of asthma. Immunology Today 1992; 13: 501-506.
6. Busse WW, Sedgwick JB, Jarjour NN, Calhoun WJ. Eosinophils and basophils in allergic airway inflammation. J Allergy Clin Immunol 1994; 94: 1250-1254.
7. Jeffery PK. Pathology of asthma. Br Med Bull 1992; 48: 23-39.
8. Jeffery PK. Pathology of asthma. In: Kay AB, ed. Allergy and Allergic Diseases. Oxford, Blackwell Science Ltd, 1997; pp. 1412-1428.
9. Frew AJ, Moqbel R, Varley J, et al. T-lymphocytes and eosinophils in allergen-induced late phase asthmatic reactions in the guinea-pig. Am Rev Respir Dis 1990; 141: 407-413.
10. Venge P. Human eosinophil granule proteins: structure, function and release. In: Smith H, Cook RM, Page C, eds. The Handbook of Immunopharmacology. London, Academic Press, 1993; pp. 43-56.
11. Filley WV, Holley KE, Kephart GM, Gleich GJ. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissue of patients with bronchial asthma. Lancet 1982; 1: 11-16.
12. Motojima S, Frigas E, Loegering DA, Gleich GJ. Toxicity of eosinophil cationic protein for guinea-pig tracheal epithelium in vitro. Am Rev Respir Dis 1989; 139: 801-805.
13. Jose PJ, Griffiths-Johnson DA, Collins PD, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation. J Exp Med 1994; 179: 881-887.
14. Jose PJ, Adcock IM, Griffiths-Johnson DA, et al. Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem Biophys Res Commun 1994; 205: 788-794.
15. Griffiths-Johnson DA, Collins PD, Rossi AG, Jose PJ, Williams TJ. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun 1993; 197: 1167-1172.
16. Rothenberg ME, Luster AD, Leder P. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci USA 1995; 92: 8960-8964.
17. Ponath PD, Qui S, Ringler DJ, et al. Cloning of the human eosinophil chemoattractant, eotaxin. J Clin Invest 1996; 97: 604-612.
18. Bartels J, Schluter C, Richter E, et al. Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression, and identification of eotaxin sequence variants. Biochem Biophy Res Commun 1996; 225: 1045-1051.
19. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996; 2: 449-456.
20. Rothenberg ME, Luster AD, Lilly CM, Drazen JM, Leder P. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea-pig lung. J Exp Med 1995; 181: 1211-1216.
21. Lilly CM, Nakamura H, Kesselman H, et al. Expression of eotaxin by human lung epithelial cells. J Clin Invest 1997; 99: 1767-1773.
22. Gonzalo J-A, Jia G-Q, Aguirre V, et al. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity 1996; 4: 1-14.
23. Humbles AA, Conroy DM, Marleau S, et al. Generation and action of an eosinophil-selective chemoattractant, eotaxin, in vivo. (Abstract). Am J Respir Crit Care Med 1996; 153: A219.
24. Robinson G, Ellis IO, MacLennan KA. Immunocytochemistry. In: Bancroft JD, Stevens A. eds. Theory and Practice of Histological Techniques. 3rd Edn. London, Churchill Livingstone, 1990; pp. 413-436.
25. Martinez-Montero JC, Herrington CS, Stickland J, et al. Model system for optimising mRNA non-isotopic in situ hybridisation: riboprobe detection of lysozyme mRNA in archival gut biopsy specimens. J Clin Pathol 1991; 44: 835-839.
26. Teran LM, Montefort S, Douglass J, Holgate ST. Neutrophil and eosinophil chemotaxins in asthma. Q J Med 1993; 86: 761-769.
27. Hansel TT, Braun RK, De Vries IJM, et al. Eosinophils and cytokines. In: New Drugs in Allergy and Asthma. Basel, Birkhauser Verlag, 1993; pp. 197-208.
28. Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 1993; 8: 349-355.
29. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA. RANTES and macrophage inflammatory protein 1a induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992; 176: 1489-1495.
30. Dahinden CA, Geiser T, Brunner T, et al. Monocyte chemoattractant protein is a most effective basophil-and eosinophil-activating chemokine. J Exp Med 1994; 179: 751-756.
31. Cromwell O, Hamid Q, Corrigan CJ, et al. Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1β and tumor necrosis factor-alpha. Immunology 1992; 77: 330-337.
32. Li D, Wang D, Majumdar S, et al. Localization and up-regulation of mucin (MUC2) gene expression in human nasal biopsies of patients with cystic fibrosis. J Pathol 1997; 181: 305-310.
33. John M, Hirst JS, Jose PJ, et al. Human airway smooth muscle cells express and release RANTES in response to T helper-1 cytokines. J Immunol 1997; 158: 1841-1847.
34. Rossi GA, Sacco O, Balbi B, et al. Human ciliate bronchial epithelial cells: expression of the HLA-DR antigens and of HLA-DR alpha gene, modulation of the HLA-DR antigens by gamma-interferon and antigen-presenting function in the mixed leucocyte reaction. Am J Resp Cell Mol Biol 1990; 3: 431-439.
35. Gant VA, Hamblin AS. Human bronchoalveolar macrophage heterogeneity demonstrated by histochemistry, surface markers and phagocytosis. Clin Exp Immunol 1985; 60: 539-545.
36. Glanville AR, Tazelaar HD, Theodore J. The distribution of MHC class I and II antigens on bronchial epithelium. Am J Resp Cell Mol Biol 1991; 4: 320-329.
37. Renzi PM, Olivenstein R, Martin JG. Inflammatory cell populations in the airways and parenchyma after antigen challenge in the rat. Am Rev Respir Dis 1993; 147: 967-974.
38. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996; 154: 1505-1510.
39. Humbles AA, Conroy DM, Marleau S, et al. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea-pig model in vivo. J Exp Med 1997; 186(4): 601-612.
40. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995; 182: 1169-1174.
41. Rothenberg ME, Mac Lean JA, Pearlman E, Luster AD, Leder P. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med 1997; 185: 785-790.
42. Burke-Gaffney A, Hellewell PG. Eotaxin stimulates eosinophil adhesion to human lung microvascular endothelial cells. Biochem Biophy Res Commun 1997; 227: 35-40.
43. Broide DH, Paine MM, Firestein GS. Eosinophils express interleukin 5 and granulocyte macrophage colony-stimulating factor mRNA at sites of allergic inflammation in asthmatic. J Clin Invest 1992; 90: 1414-1424.